Founded in 1990, Pharmexa is a biotechnology company focusing on the development of novel immunotherapy drugs to treat oncological and inflammatory diseases. Pharmexa's aim is to become the leading active immunotherapy company in the world, because the company believes this position will be attractive to hold in the second half of this decade.
Partnerships
To view this information, you must subscribe to PL Intelligence.
Deals
To view this information, you must subscribe to PL Intelligence.
Senior management
To view this information, you must subscribe to PL Intelligence.
Board of directors
To view this information, you must subscribe to PL Intelligence.
Contact details
To view this information, you must subscribe to PL Intelligence.
All rights reserved. Terms and Conditions | Contact us
